Extended-spectrum β-lactamase-producing bacterial infections in adult solid organ transplant recipients

Annals of Pharmacotherapy

Volumn 45, Issue 3, 2011, Pages 309-316

  Winters, Holli A ^a   Parbhoo, Rupal K ^a   Schafer, Jason J ^b   Goff, Debra A ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Carbapenem; Extended spectrum lactamase; Infection control; Solid organ transplant

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; BETA LACTAMASE; CEFAZOLIN; CEFEPIME; CEPHALOSPORIN; CIPROFLOXACIN; CYCLOSPORIN; ERTAPENEM; IMIPENEM; LINEZOLID; MYCOPHENOLIC ACID; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; BILIARY TRACT INFECTION; CLINICAL ARTICLE; DISEASE DURATION; ESCHERICHIA COLI INFECTION; FEMALE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE INFECTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; PANCREAS TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; URINARY TRACT INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMASES; CARBAPENEMS; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIA; HUMANS; KIDNEY TRANSPLANTATION; KLEBSIELLA INFECTIONS; LIVER TRANSPLANTATION; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PANCREAS TRANSPLANTATION; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952647944     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P661     Document Type: Article

References (38)

1. Jacoby GA and Munoz-Price S. The new beta-lactamases. N Engl J Med 2005;352:380-91.
2. Burgess DS, Hall RG, Lewis JS II, Jorgensen JH, Patterson JE. Clinical and microbiologic analysis of a hospital's extended-spectrum β-lactamase-producing isolates over a 2-year period. Pharmacotherapy 2003;23:1232-7. (Pubitemid 37221917)
3. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-62.
4. Lee SY, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Impact of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 2006;27:1226-32.
5. Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum β- lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007;51:1987-94.
6. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement (CLSI document M100-S20). Wayne, PA: Clinical Laboratory Standards Institute, 2010.
7. Kutinova A, Woodward RS, Ricci JF and Brennan DC. The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006;6:129-39. (Pubitemid 43382211)
8. Säemann M, Hörl WH. Urinary tract infection in renal transplant recipients. Eur J Clin Invest 2008;38(Supp2):58-65.
9. Audard V, Amor M, Desvaux D, et al. Acute graft pyelonephritis: a potential cause of acute rejection in renal transplant. Transplantation 2005;80:1128-30. (Pubitemid 41611939)
10. Dupont PJ, Psimenou E, Lord R, Buscombe JR, Hilson AJ, Sweny P. Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux. Transplantation 2007;84:351-5. (Pubitemid 47258323)
11. Martínez JA, Aguilar J, Almela M, et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. J Antimicrob Chemother 2006;58:1082-5.
12. Qureshi ZA, Paterson DL, Pakstis DL, et al. Risk factors and outcome of extended-spectrum beta-lactamase-producing Enterobacter cloacae bloodstream infections. Int J Antibicrob Agents 2011;37:26.32.
13. Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastros MG. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients. Transplant Proc 2010;42:486-7.
14. Linares L, Carvera C, Cofán F, et al. Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant 2008;8:1000-5. (Pubitemid 351537771)
15. Geerlings SE, van Donselaar-van der Pant KA, Keur I. Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother 2010;65:2048-9.
16. Mlynarczyk A, Mlynarczyk G, Pupek J, et al. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity. Transplant Proc 2007;39:2879-82.
17. Mlynarczyk A, Szymanek K, Sawicka-Grzelak A, et al. CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients. Transplant Proc 2009;41:3253-5.
18. Zhou JD, Guo JJ, Zhang Q, Chen Y, Zhu SH, Peng HY. Drug resistance of infectious pathogens after liver transplantation. Hepatobiliary Pancreat Dis Int 2006;5:190-4. (Pubitemid 43826905)
19. Linares L, Garcia-Goez JF, Cervera C, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009;41:2262-4.
20. Martins IS, Moreira BM, Riley LW, Santoro-Lopes G. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection among renal transplant recipients. J Hosp Infect 2006;64:305-8.
21. Chen YG, Zhang Y, Yu YS, et al. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases. Int J Antimicrob Agents 2008;32:302-7.
22. Chen H, Zhang Y, Chen YG, Yu YS, Zheng SS, Li LJ. Sepsis resulting from Enterobacter aerogenes resistant to carbapenems after liver transplantation. Hepatobiliary Pancreat Dis Int 2009;8:320-2.
23. Kawecki D, Chmura A, Pacholczyk M, et al. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc 2007;39:2816-21. (Pubitemid 350088079)
24. Kawecki D, Chmura A, Packolczyk M, et al. Bacterial infections in the early period after liver transplantation: etiological agenda and their susceptibility. Med Sci Monit 2009;15:CR628-37.
25. Milczarczyk A, Filczak K, Serwacka A, Durlik M, Rydzewski A, Franek E. Bacterial infections as complications in patients within 3 months after simultaneous pancreas-kidney transplantation. Pol Arch Med Wewn 2008;118:700-4.
26. Bellier C, Bert F, Durand F, et al. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008;21:755-63.
27. Johnson JR, Johnston B, Clabots C, et al. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob Agents Chemother 2010;54:546-50.
28. Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc 2006;38:2414-5. (Pubitemid 44767859)
29. Moreno A, Cervera C, Gavaldá J, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 2007;7:2579-86. (Pubitemid 47561608)
30. Singh N, Wagener MM, Obman A, Cacciarelli TV, de Vera ME, Gayowski T. Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 2004;10:844-9. (Pubitemid 38979253)
31. Linares L, Cervera C, Cofán F, et al. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 2007;39:2222-4. (Pubitemid 47418169)
32. Linares L, Cervera C, Hoyo I, et al. Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance. Transplant Proc 2010;42:2941-3.
33. Singh N, Gayowski T, Rihs JD, Wagener MM, Marino IR. Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transpl 2001;7:22-6. (Pubitemid 32060909)
34. Mathers AJ, Cox HL, Bonatti J, et al. Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis 2009;11:257-65.
35. Bassetti M, Salvalaggio PR, Topal J, et al. Incidence, timing and site of infections among pancreas transplant recipients. J Hosp Infect 2004;56:184-90. (Pubitemid 38262945)
36. De Souza RM and Olsburgh J. Urinary tract infection in the renal transplant patient. Nat Clin Pract Nephrol 2008;4:252-64. (Pubitemid 351589731)
37. Bellier C, Bert F, Durand F, et al. Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int 2008;21:755-63.
38. Gouvêa EF, Branco RC, Monteiro RC, et al. Outcome of infections caused by multiple drug-resistant bacteria in liver transplant recipients. Transplant Proc 2004;36:958-60. (Pubitemid 38766239)